tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

INAB Stock Latest News

IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Press ReleasesIN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
13d ago
INAB
IN8bio price target raised to $6.50 from $5 at JonesResearch
PremiumThe Fly
IN8bio price target raised to $6.50 from $5 at JonesResearch
23d ago
INAB
IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100
PremiumPress Releases
IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100
24d ago
INAB
IN8bio presents updated data from Phase 1 trial of INB-100 at EHA
PremiumThe Fly
IN8bio presents updated data from Phase 1 trial of INB-100 at EHA
24d ago
INAB
IN8bio presents PFS update from Phase 1 study of INB-200
PremiumThe Fly
IN8bio presents PFS update from Phase 1 study of INB-200
1M ago
INAB
IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting
PremiumPress ReleasesIN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting
1M ago
INAB
IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
PremiumPress Releases
IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
1M ago
INAB
IN8bio announces multiple presentations at ISCT 2024
PremiumThe Fly
IN8bio announces multiple presentations at ISCT 2024
1M ago
INAB
IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting
PremiumPress Releases
IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting
1M ago
INAB
IN8bio announces INB-200 Phase 1 data in newly diagnosed glioblastoma
PremiumThe Fly
IN8bio announces INB-200 Phase 1 data in newly diagnosed glioblastoma
1M ago
INAB
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
PremiumPress Releases
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
2M ago
INAB
IN8bio presented data on gamma-delta T cell manufacturing platform
PremiumThe Fly
IN8bio presented data on gamma-delta T cell manufacturing platform
2M ago
INAB
IN8bio price target lowered to $12.50 from $14 at H.C. Wainwright
PremiumThe FlyIN8bio price target lowered to $12.50 from $14 at H.C. Wainwright
2M ago
INAB
IN8bio reports Q1 EPS (20c), consensus (18c)
PremiumThe Fly
IN8bio reports Q1 EPS (20c), consensus (18c)
2M ago
INAB
INAB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
INAB Upcoming Earnings Report: What to Expect?
2M ago
INAB
IN8bio begins dosing in Phase 2 trial of INB-400 in newly diagnosed glioblastoma
PremiumThe Fly
IN8bio begins dosing in Phase 2 trial of INB-400 in newly diagnosed glioblastoma
2M ago
INAB
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
PremiumPress Releases
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
2M ago
INAB
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
PremiumPress Releases
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
3M ago
INAB
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
PremiumPress Releases
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
3M ago
INAB
IN8bio: Data for Gamma-Delta nsCAR-T cell therapy platform presented at AACR
PremiumThe FlyIN8bio: Data for Gamma-Delta nsCAR-T cell therapy platform presented at AACR
3M ago
INAB
IN8bio initiated with a Buy at Laidlaw
PremiumThe Fly
IN8bio initiated with a Buy at Laidlaw
4M ago
INAB
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
4M ago
INAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >